Check out the playback of Akari’s virtual KOL event, PAS Nomacopan Potential in Geographic Atrophy (GA), featuring Elias Reichel, M.D., Tufts University School …
Stories
Join Us for a Virtual KOL Event
Join us for a virtual KOL event with Akari Therapeutics, featuring Elias Reichel, MD (Tufts University School of Medicine) who will discuss …
Check out the discussion transcript from The Science Huddle: Small Data Big Outcomes
CLICK TO READ ENTIRE TRANSCRIPT With the reach and impact of biopharma growing exponentially, experts in biotech and the evolving regulatory environment came …
Akari on the Business of Biotech podcast
Ticks aren’t all bad! Check out the Business of Biotech podcast to hear how Akari engineered #nomacopan, a recombinant protein derived from ticks, and scaled …
[Read more...] about Akari on the Business of Biotech podcast
Rich Database Underpins Predictive PK/PD Model
Akari clinical data from 38 subjects (in previous clinical studies and healthy volunteers) support robust PK/PD model simulations used to select doses for …
[Read more...] about Rich Database Underpins Predictive PK/PD Model
